Showing 1,141 - 1,160 results of 3,784 for search '"hypertension"', query time: 0.10s Refine Results
  1. 1141
  2. 1142
  3. 1143
  4. 1144

    Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis by Ci Song, Peter Kunovszki, Amélie Beaudet

    Published 2022-06-01
    “…Eligible patients were ≥18 years of age with ≥1 ICD-9-CM or ICD-10-CM diagnosis code indicating pulmonary hypertension and no diagnosis code suggesting Group 3–5 pulmonary hypertension. …”
    Get full text
    Article
  5. 1145
  6. 1146
  7. 1147

    Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model by Cheuk-Kwan Sun, Yen-Yi Zhen, Hung-I Lu, Pei-Hsun Sung, Li-Teh Chang, Tzu-Hsien Tsai, Jiunn-Jye Sheu, Yung-Lung Chen, Sarah Chua, Hsueh-Wen Chang, Yi-Ling Chen, Fan-Yen Lee, Hon-Kan Yip

    Published 2014-01-01
    “…We tested the hypothesis that Lipofectamine siRNA delivery to deplete transient receptor potential cation channel (TRPC) 1 protein expression can suppress hypoxia-induced pulmonary arterial hypertension (PAH) in mice. Adult male C57BL/6 mice were equally divided into group 1 (normal controls), group 2 (hypoxia), and group 3 (hypoxia + siRNA TRPC1). …”
    Get full text
    Article
  8. 1148
  9. 1149

    Knowledge, attitudes and practices of healthcare professionals in the management of patients with hypertension and concurrent bronchial asthma: a cross-sectional study in the Yellow River Delta region of China by Yang Yang, Wenwen Xu, Fei Yu, Xiaohong Yan, Xingbin Ma, Jinxiang Gao

    Published 2025-01-01
    “…Objective To assess the Knowledge, Attitudes and Practices (KAP) among healthcare professionals in managing patients with coexisting hypertension and bronchial asthma.Design A cross-sectional survey. …”
    Get full text
    Article
  10. 1150
  11. 1151
  12. 1152
  13. 1153
  14. 1154

    Chitosan-Based Hemostatic Pad Reduced Vascular Complications After Transradial Coronary Intervention in Uncontrolled Hypertensive Patients: Application of Chitosan-Based Hemostatic Pad on CAG or PCI by Lu Qian, Ming-Qiang Cao, Ze-Xiong Feng, Cao Zou, Si-Jia Sun, Sheng-Da Hu

    Published 2024-01-01
    “…Conclusions: Chitosan-based HP treatment could reduce the incidence of vascular complications in patients with uncontrolled hypertension. Nonetheless, applying chitosan-based HP treatment after CAG or PCI procedures is not recommendable for controlled hypertensive patients.…”
    Get full text
    Article
  15. 1155
  16. 1156

    Bayes Conditional Probability-Based Causation Analysis between Gestational Diabetes Mellitus (GDM) and Pregnancy-Induced Hypertension (PIH): A Statistic Case Study in Harbin, China by Dan Diao, Fang Diao, Bin Xiao, Ning Liu, Dan Zheng, Fengjuan Li, Xu Yang

    Published 2022-01-01
    “…Both gestational diabetes mellitus (GDM) and pregnancy-induced hypertension (PIH) would influence the gestation significantly. …”
    Get full text
    Article
  17. 1157

    Body Weight Control by a High-Carbohydrate/Low-Fat Diet Slows the Progression of Diabetic Kidney Damage in an Obese, Hypertensive, Type 2 Diabetic Rat Model by Shuichi Ohtomo, Yuko Izuhara, Masaomi Nangaku, Takashi Dan, Sadayoshi Ito, Charles van Ypersele de Strihou, Toshio Miyata

    Published 2010-01-01
    “…Obesity is one of several factors implicated in the genesis of diabetic nephropathy (DN). Obese, hypertensive, type 2 diabetic rats SHR/NDmcr-cp were given, for 12 weeks, either a normal, middle-carbohydrate/middle-fat diet (MC/MF group) or a high-carbohydrate/low-fat diet (HC/LF group). …”
    Get full text
    Article
  18. 1158
  19. 1159
  20. 1160